We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+7.62%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.79B
AUM Growth
+$164M
Cap. Flow
-$30.9M
Cap. Flow %
-1.11%
Top 10 Hldgs %
20.45%
Holding
3,380
New
284
Increased
506
Reduced
861
Closed
334

Top Buys

Rank Stock Value
1
AFL icon
Aflac
AFL
+$2.88M
2
AZPN
ASPEN TECHNOLOGY INC
AZPN
+$2.53M
3
TRGP icon
Targa Resources
TRGP
+$2.39M
4
UNP icon
Union Pacific
UNP
+$2.39M
5
G icon
Genpact
G
+$2.13M

Sector Composition

Rank Sector Weight
1 Technology 17.21%
2 Financials 10.71%
3 Consumer Discretionary 10.62%
4 Healthcare 9.54%
5 Industrials 9.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRMK
1651
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
$111K ﹤0.01%
10,466
KOS icon
1652
Kosmos Energy
KOS
$1.51B
$110K ﹤0.01%
31,772
-3,843
-11% -$11.9K
KYMR icon
1653
Kymera Therapeutics
KYMR
$9.51B
$110K ﹤0.01%
2,267
+1,422
+168% +$61.7K
MLAB icon
1654
Mesa Laboratories
MLAB
$633M
$110K ﹤0.01%
404
OPI
1655
DELISTED
Office Properties Income Trust
OPI
$110K ﹤0.01%
3,755
-437
-10% -$12.5K
HMHC
1656
DELISTED
Houghton Mifflin Harcourt Company
HMHC
$110K ﹤0.01%
9,969
+889
+10% +$8.37K
SAFE
1657
DELISTED
Safehold Inc.
SAFE
$110K ﹤0.01%
1,403
-125
-8% -$9.01K
ALK icon
1658
Alaska Air
ALK
$5.3B
$109K ﹤0.01%
1,813
AVIR icon
1659
Atea Pharmaceuticals
AVIR
$406M
$109K ﹤0.01%
5,064
+3,849
+317% +$116K
FCF icon
1660
First Commonwealth Financial
FCF
$2.19B
$109K ﹤0.01%
7,774
KURA icon
1661
Kura Oncology
KURA
$896M
$109K ﹤0.01%
5,246
MDXG icon
1662
MiMedx Group
MDXG
$612M
$109K ﹤0.01%
+8,710
New +$94.3K
EXTR icon
1663
Extreme Networks
EXTR
$3.16B
$108K ﹤0.01%
9,679
-1,069
-10% -$11.3K
UVV icon
1664
Universal Corp
UVV
$1.12B
$108K ﹤0.01%
1,896
-180
-9% -$10.4K
PGTI
1665
DELISTED
PGT, Inc.
PGTI
$108K ﹤0.01%
4,639
HYLN icon
1666
Hyliion Holdings
HYLN
$734M
$107K ﹤0.01%
+9,193
New +$96.1K
IPAR icon
1667
Interparfums
IPAR
$3.7B
$107K ﹤0.01%
1,484
KFRC icon
1668
Kforce
KFRC
$1.08B
$107K ﹤0.01%
1,698
LADR
1669
Ladder Capital
LADR
$1.27B
$107K ﹤0.01%
9,254
AAMI
1670
Acadian Asset Management
AAMI
$3.31B
$107K ﹤0.01%
4,548
-877
-16% -$20K
TEN
1671
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$107K ﹤0.01%
5,542
+1,302
+31% +$19.5K
ADUS icon
1672
Addus HomeCare
ADUS
$2.2B
$106K ﹤0.01%
1,220
AZZ icon
1673
AZZ Inc
AZZ
$4.52B
$106K ﹤0.01%
2,055
MATV icon
1674
Mativ Holdings
MATV
$667M
$106K ﹤0.01%
2,615
SCS
1675
DELISTED
Steelcase
SCS
$106K ﹤0.01%
7,018

Similar funds

Ameritas Investment Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Ameritas Investment Partners held 3,380 positions worth $2.79B, up 6.2% from $2.62B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Ameritas Investment Partners's Q2 2021 filing shows 284 new, 506 increased, 861 reduced and 334 closed positions. Its largest new stake was ASPEN TECHNOLOGY INC: 18,384 shares worth $2.53M. The largest sale was Charles River Laboratories, an estimated $5.13M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Ameritas Investment Partners's largest Q2 2021 buy was ASPEN TECHNOLOGY INC: 18,384 shares worth $2.53M.
  • Ameritas Investment Partners added most to Aflac in Q2 2021, an estimated $2.88M increase.
  • Ameritas Investment Partners's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $5.13M.
  • Ameritas Investment Partners fully exited TCF Financial Corporation Common Stock in Q2 2021, selling an estimated $1.96M.
  • Ameritas Investment Partners's ten largest holdings make up 20% of its $2.79B portfolio in Q2 2021.
  • Ameritas Investment Partners opened 284 new positions and closed 334 in Q2 2021.
  • Ameritas Investment Partners's portfolio value rose 6.2% quarter-over-quarter to $2.79B.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.